CM Life Sciences II Inc. (CMIIU) Prices Upsized $240M IPO

CM Life Sciences II Inc. announced the pricing of its upsized $240 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “CMIIU,” Tuesday, February 23.

CM Life Sciences II intends to focus on the life sciences sector. The company is led by Chairman Keith A. Meister and Chief Executive Officer and Director Eli D. Casdin.

Total SPAC deal count for 2021 year-to-date is now 164. This offering is expected to close on Thursday, February 25.

Jefferies LLC is acting as sole book-running manager of the offering. White & Case LLP is serving as Issuer’s Counsel with Skadden, Arps, Slate, Meagher & Flom LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.